Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPAR&#945;/Î³: Involvement of ROS/NF-&#954;B/IRS1 Signaling Pathway.

Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/Î³: Involvement of ROS/NF-κB/IRS1 Signaling Pathway.

Li, Yiqi; Li, Yeli; Chen, Nana; Feng, Linying; Gao, Jianmei; Zeng, Nan; He, Zhixu; Gong, Qihai.

Afiliación

Li Y; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Li Y; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Chen N; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Feng L; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Gao J; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Zeng N; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
He Z; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Gong Q; The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine, Zunyi Medical University, Zunyi 563000, China.

Antioxidants (Basel) ; 11(9)2022 Aug 30.

Article en En | MEDLINE | ID: mdl-36139776